[1]
Lajthia, E., Bucheit, J.D., Nadpara, P.A., Dixon, D.L., Caldas, L.M., Murchie, M. and Sisson, E.M. 2019. Combination therapy with once-weekly glucagon like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes: a case series. Pharmacy Practice. 17, 4 (Dec. 2019), 1588. DOI:https://doi.org/10.18549/PharmPract.2019.4.1588.